CEMI - Chembio Diagnostics GAAP EPS of -$0.23 revenue of $9.2M August, 04 2022 04:15 PM Chembio Diagnostics Inc. Chembio Diagnostics press release ( NASDAQ: CEMI ): Q2 GAAP EPS of -$0.23. Revenue of $9.2M (+41.5% Y/Y). For further details see: Chembio Diagnostics GAAP EPS of -$0.23, revenue of $9.2M